Patch testing of budesonide in Italy: The SIDAPA baseline series experience, 2018-2019.

We documented a low prevalence of budesonide allergy in Italy, confirming its decreasing trend recently reported in the literature. Nevertheless, budesonide needs to be maintained in the baseline series for its good ability to detect corticosteroid sensitization.